for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Ironwood Pharma's digestive disease drug fails late-stage study

Sept 29 (Reuters) - Ironwood Pharmaceuticals Inc said on Tuesday its therapy to treat refractory gastroesophageal reflux disease failed to significantly reduce heartburn severity in a late-stage trial.

The company said it plans to reduce its workforce by nearly 35%, or 100 employees.

Reporting by Dania Nadeem in Bengaluru; Editing by Shinjini Ganguli

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up